ArticleCancer medicine2025

End-Of-Life Outcomes and Healthcare Utilization for Patients With Hepatocellular Carcinoma Who Received Immune Checkpoint Inhibition.

Margaret C Wheless et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.